Why Analysts See a Shifting Story for Elutia After the BioEnvelope Sale [Yahoo! Finance]
Boston Scientific Corporation (BSX)
Last boston scientific corporation earnings: 4/29 06:30 am
Check Earnings Report
US:NYSE Investor Relations:
investors.bostonscientific.com
Company Research
Source: Yahoo! Finance
Alongside this decrease, the discount rate has increased from 8.24% to 8.55%, signaling growing uncertainty or perceived risk in Elutia's future cash flows. Stay tuned to discover what is driving these narrative shifts and how you can monitor future updates as the company navigates new strategic changes. Analyst Price Targets don't always capture the full story. Head over to our Company Report to find new ways to value Elutia. What Wall Street Has Been Saying Recent analyst commentary has focused on Elutia's strategic moves and their implications for the company's valuation and future prospects. Lake Street offered detailed perspectives following the firm's latest business developments. ?? Bullish Takeaways Lake Street maintains a Buy rating on Elutia shares, even though the price target was lowered to $6 from $8. This reflects ongoing confidence in the company's longer-term prospects. The sale of the BioEnvelope business to Boston Scientific for $88 million is expected to
Show less
Read more
Impact Snapshot
Event Time:
BSX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BSX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BSX alerts
High impacting Boston Scientific Corporation news events
Weekly update
A roundup of the hottest topics
BSX
News
- What Could Shift the Story for Boston Scientific After Strong Results and Analyst Optimism [Yahoo! Finance]Yahoo! Finance
- Boston Scientific (NYSE:BSX) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $132.00 price target on the stock.MarketBeat
- Boston Scientific Corporation's (NYSE:BSX) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong? [Yahoo! Finance]Yahoo! Finance
- The 7 Things That Make You Interesting In 2026 [Forbes]Forbes
- Cala Health Expands Leadership Team to Support Growing Adoption of the Cala TAPS Therapy for Tremor [Yahoo! Finance]Yahoo! Finance
BSX
Earnings
- 10/22/25 - Beat
BSX
Sec Filings
- 12/2/25 - Form 4
- 12/1/25 - Form 4
- 12/1/25 - Form 144
- BSX's page on the SEC website